Ruben Carrasco
Assistant Professor
Hematologic OncologyÂ
Dana-Farber Cancer Institute
United States of America
Biography
Dr. Carrasco received his MD in 1991 from the University of Chile School of Medicine. He trained in surgical pathology and hematopathology at Massachusetts General Hospital and Brigham and Women's Hospital; he is board-certified in both fields. In 2001, he worked in the laboratory of Dr. Ronald DePinho as a postdoctoral research fellow. After completing this training, Dr. Carrasco joined the faculty in 2004. He has a long-standing interest in hematological malignancies and is currently investigating the genetic events leading to disease pathogenesis in multiple myeloma.
Research Interest
Hematologic Oncology
Publications
-
Carrasco DR, Sukhdeo K, Protopopova M, Sinha R, Enos M (2007) The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell 4 :349-360.
-
Zhao JJ, Carrasco RD (2014) Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapy. Cancer Res 19 :5351-5358.
-
Elsarraj HS, Hong Y, Valdez KE, Michaels W, Hook M et al (2015) Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion. Breast Cancer Res17 :128.
